Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1955 1
1956 2
1962 2
1963 1
1964 1
1969 1
1971 1
1974 2
1975 2
1976 5
1977 8
1978 8
1979 3
1980 4
1981 1
1982 9
1983 1
1984 4
1985 4
1986 8
1987 12
1988 11
1989 6
1990 12
1991 9
1992 6
1993 12
1994 16
1995 9
1996 12
1997 14
1998 14
1999 9
2000 18
2001 19
2002 26
2003 27
2004 30
2005 35
2006 42
2007 66
2008 67
2009 74
2010 96
2011 82
2012 95
2013 109
2014 106
2015 153
2016 133
2017 116
2018 76
2019 144
2020 170
2021 226
2022 222
2023 189
2024 156
2025 178

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,568 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. Doki Y, et al. Among authors: hsu ch. N Engl J Med. 2022 Feb 3;386(5):449-462. doi: 10.1056/NEJMoa2111380. N Engl J Med. 2022. PMID: 35108470 Clinical Trial.
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma.
Zhu AX, Abbas AR, de Galarreta MR, Guan Y, Lu S, Koeppen H, Zhang W, Hsu CH, He AR, Ryoo BY, Yau T, Kaseb AO, Burgoyne AM, Dayyani F, Spahn J, Verret W, Finn RS, Toh HC, Lujambio A, Wang Y. Zhu AX, et al. Among authors: hsu ch. Nat Med. 2022 Aug;28(8):1599-1611. doi: 10.1038/s41591-022-01868-2. Epub 2022 Jun 23. Nat Med. 2022. PMID: 35739268
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K, Doki Y, Chau I, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Makino T, Blum Murphy M, Amaya-Chanaga C, Patel A, Hu N, Matsumura Y, Kitagawa Y, Ajani J. Kato K, et al. Among authors: hsu ch. Cancer Med. 2024 May;13(9):e7235. doi: 10.1002/cam4.7235. Cancer Med. 2024. PMID: 38716626 Free PMC article. Clinical Trial.
Progress Toward Measles Elimination - Worldwide, 2000-2022.
Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hatcher C, Hsu CH, Ho LL, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Caro WP, O'Connor P, Crowcroft NS. Minta AA, et al. Among authors: hsu ch. MMWR Morb Mortal Wkly Rep. 2023 Nov 17;72(46):1262-1268. doi: 10.15585/mmwr.mm7246a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37971951 Free PMC article.
Progress Toward Measles Elimination - Worldwide, 2000-2023.
Minta AA, Ferrari M, Antoni S, Lambert B, Sayi TS, Hsu CH, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Wimmer A, Bose AS, O'Connor P, Crowcroft NS. Minta AA, et al. Among authors: hsu ch. MMWR Morb Mortal Wkly Rep. 2024 Nov 14;73(45):1036-1042. doi: 10.15585/mmwr.mm7345a4. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39541251 Free PMC article.
Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.
Lee YR, Chen M, Lee JD, Zhang J, Lin SY, Fu TM, Chen H, Ishikawa T, Chiang SY, Katon J, Zhang Y, Shulga YV, Bester AC, Fung J, Monteleone E, Wan L, Shen C, Hsu CH, Papa A, Clohessy JG, Teruya-Feldstein J, Jain S, Wu H, Matesic L, Chen RH, Wei W, Pandolfi PP. Lee YR, et al. Among authors: hsu ch. Science. 2019 May 17;364(6441):eaau0159. doi: 10.1126/science.aau0159. Science. 2019. PMID: 31097636 Free PMC article.
2,568 results